Nada Amllal

Ms. Nada Amllal


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2024 in Molecular Syndromology
Verified
Journal Article
Closed access
PDF file
NANada Amllal
Nada Amllal
JLJaber Lyahyai
Jaber Lyahyai
SESiham Chafai Elalaoui
Siham Chafai Elalaoui
YKYoussef El Kadiri
Youssef El Kadiri
ASAbdelaziz Sefiani
Abdelaziz Sefiani
Introduction: Pathogenic variants in the STXBP1 gene are associated to a large spectrum of severe early onset developmental and epileptic encephalopathies (OMIM #612164). They were also identified in various other neurodevelopmental disorders. This gene encodes for the syntaxin-binding protein 1, a member of the SEC-1 family of membrane-transport proteins that modulate the presynaptic vesicular fusion by interacting with soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs). However, the physiopathology of STXBP1 pathogenic variants is not yet fully understood. Case Presentation: Herein, we report a patient presenting intellectual disability, early onset seizures, and autism. Clinical exome sequencing identified a novel monoallelic splice pathogenic variant STXBP1(NM_001032221.6):c.38–2A>G. Discussion: Splice-site pathogenic variants in the STXBP1 gene are mostly associated with West syndrome, early onset epilepsy and encephalopathy, and Ohtahara syndrome. Our findings extend clinical and molecular spectrum of STXBP1 gene variants by reporting the first splice-site variant associated with autism along with early onset epilepsy and, and intellectual disability in a patient.

4 September 2023 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
NANada Amllal
Nada Amllal
SES. Chafai Elalaoui
S. Chafai Elalaoui
MZMaria Zerkaoui
Maria Zerkaoui
ACAmal Chiguer
Amal Chiguer
LALamia Afif
Lamia Afif
JLJaber Lyahyai
Jaber Lyahyai
Nada Amllal, Ph.D., Siham Chafai Elalaoui, M.D., Maria Zerkaoui, M.D., Amal Chiguer, M.D., Lamia Afif, M.D., Amal Thimou Izgua, M.D., Abdelaziz Sefiani, M.D., and Jaber Lyahyai, Ph.D.. Ann Lab Med 2024;44:110-7. https://doi.org/10.3343/alm.2024.44.1.110

8 November 2024 in Epileptic Disorders
Verified
Journal Article
Closed access
NANada Amllal
Nada Amllal
JLJaber Lyahyai
Jaber Lyahyai
LALamiae Afif
Lamiae Afif
YKYamna Kriouile
Yamna Kriouile
ASAbdelaziz Sefiani
Abdelaziz Sefiani
SESiham Chafai Elalaoui
Siham Chafai Elalaoui

19 September 2024 in International Journal of Developmental Neuroscience
Verified
Journal Article
Closed access
NBNada Benyahya
Nada Benyahya
NANada Amllal
Nada Amllal
SES. Chafai Elalaoui
S. Chafai Elalaoui
MAMustapha El Alloussi
Mustapha El Alloussi
ASAbdelaziz Sefiani
Abdelaziz Sefiani
JLJaber Lyahyai
Jaber Lyahyai

3 August 2024 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
NANada Amllal
Nada Amllal
MZMaria Zerkaoui
Maria Zerkaoui
WJWafaa Jdioui
Wafaa Jdioui
SESiham Chafai Elalaoui
Siham Chafai Elalaoui
ASAbdelaziz Sefiani
Abdelaziz Sefiani
JLJaber Lyahyai
Jaber Lyahyai

6 January 2026 in Molecular Syndromology
Verified
Journal Article
Closed access
HBHicham Bouchahta
Hicham Bouchahta
MSMaryem Sahli
Maryem Sahli
NANada Amllal
Nada Amllal
MOMouna Ouhenach
Mouna Ouhenach
LSLaila Sbabou
Laila Sbabou
ASAbdelaziz Sefiani
Abdelaziz Sefiani
Introduction: TRIO-associated neurodevelopmental disorders are rare genetic conditions caused by pathogenic variants in the TRIO gene, which plays a crucial role in neuronal development. Mutations in the TRIO gene are increasingly associated with autosomal dominant inheritance. However, de novo occurrences in dizygotic twins remain rare and poorly understood. Case Presentation: In this work, clinical exome sequencing (CES) was performed on dizygotic twin sisters who presented with neurodevelopmental delay, intellectual disability, behavioral issues, and microcephaly. Segregation analysis using conventional Sanger sequencing was conducted on the parents to assess the inheritance pattern. A pathogenic missense variant c.4283G>A (p.Arg1428Gln) in the GEFD1 domain of the TRIO gene was identified. This variant is known to reduce GEF activity toward Rac1, impacting neuronal signaling pathways. Segregation analysis did not detect the variant in the parents, and mosaicism remains a possibility that could not be fully ruled out due to the limitations of this technique. Despite the lack of a definitive molecular diagnosis in the parents, detailed genetic counseling was provided to the family. Conclusion: These findings highlight the diagnostic value of CES in rare neurodevelopmental disorders and suggest a plausible but unproven parental germline or early postzygotic mosaic event, while acknowledging alternative explanations.